Origin Agritech Limited develops agricultural technology and crop seed biotechnology in China, with news centered on corn seed R&D, genetic improvement, commercialization programs, and regulatory authorizations for crop seed production and GMO-related operations. Company updates frequently cover new corn varieties such as Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, as well as distributor initiatives including the Golden Harvest Club.
Recurring developments also include biotechnology pipeline work involving glyphosate tolerance, Bt pest-resistance traits, phytase corn, gene editing technology, research collaborations, market expansion in Chinese agricultural regions, annual results, financing actions, and board or finance leadership changes.
Origin Agritech Ltd. (NASDAQ: SEED) has appointed PCG Advisory, Inc. as its new investor relations firm. This collaboration aims to enhance the company's marketing strategies to a broader investment community amidst China's agricultural modernization efforts. Dr. Gengchen Han, the Chairman, highlighted the critical role Origin will play in this initiative. PCG Advisory's CEO, Jeff Ramson, expressed enthusiasm about promoting Origin's compelling investment story, targeting both agriculture technology and growth investors.
Origin Agritech Ltd. (NASDAQ: SEED) has entered an exclusive rights agreement with the Biology Research Institute of the Chinese Academy of Agricultural Sciences for a drought-resistant GMO trait. The agreement grants Origin global rights to the trait, which has shown a yield increase of 9.2-16.2% over non-GMO corn in water-stressed conditions and improved water use efficiency by 33-47% under irrigated conditions. The Ministry of Agriculture has approved the trait for production trials, marking a significant step towards commercialization. This development aligns with the growing focus on drought resistance amid climate change.
Origin Agritech Ltd. (NASDAQ: SEED) has received approval from the Ministry of Agriculture and Rural Affairs in China for four new hybrid corn breeds. This approval enhances the company's product pipeline and competitiveness in China's corn seed market. Origin is also working on GMO-enhanced versions of these hybrids, further streamlining the approval process. Dr. Gengchen Han, Chairman of Origin Agritech, expressed optimism about expanding germplasm resources to support the development of GMO hybrid seeds.
Origin Agritech Ltd. (NASDAQ: SEED) announced significant progress in the official government trials of GMO corn hybrid varieties. One herbicide-resistant variety has completed its final trial and awaits approval, while five double-stack GMO corn hybrids have moved to the second-year trials. Additionally, three new hybrids are set for first-year trials next year, totaling 27 hybrids at various evaluation stages. Thirteen GMO Phytase varieties are also pending final approval. The company emphasizes the importance of these developments for future market readiness.
Origin Agritech Ltd. (NASDAQ: SEED) announced that Chairman Dr. Gengchen Han was interviewed by The Wall Street Resource Podcast. The discussion highlighted the company's significant investments in research, positioning it to benefit from China's expected approval of GMO crops, a market estimated to be worth billions. Dr. Han emphasized that this opportunity is primarily reserved for domestic firms. Origin Agritech has pioneered various biotech seeds and continues to develop a strong product pipeline, contributing to its competitive advantage in the agricultural sector.
Origin Agritech Ltd. (NASDAQ: SEED) has entered a collaboration agreement with Beijing Dabeinong Technology Group to develop commercial GMO corn hybrids. This partnership aims to integrate DBN's approved traits with Origin's elite hybrids to enhance corn production for Chinese farmers. The agreement may also lead to joint efforts in GMO seed production and marketing. DBN is a major Chinese agriculture firm with significant market presence, while Origin boasts a substantial corn seed germplasm collection and a strong GMO pipeline.
Origin Agritech Ltd. (NASDAQ: SEED) announced the development of new corn traits that enhance drought resistance and provide protection against southern rust, significant threats to crop yields. Leveraging over 20 years of advanced germplasm development, these traits are crucial as drought can reduce yields by over 30% and southern corn rust by 45%. Recent drought conditions affecting 475,333 hectares in China highlight the immediate need for these resilient crops. Chairman Dr. Gengchen Han emphasized the importance of responsiveness to farmers' needs in the face of climate change.
Origin Agritech Ltd. (NASDAQ: SEED) announced advancements in gene editing technology for developing new corn traits. The Biotechnology Center of Beijing Origin Seed has created traits that reduce plant height and increase chloroplast content. These innovations aim to enhance corn seed production and meet the growing acceptance of GMOs in China. Origin's Chairman, Dr. Gengchen Han, expressed excitement about the potential of these traits in capitalizing on market trends.
Origin Agritech Ltd. (NASDAQ: SEED) has provided an update on the commercialization of GMO seeds in China, following a significant statement from the Central Economic Work Conference. The government plans to industrialize biotech breeding to enhance food security. Origin is prepared to supply various GMO corn and soybean seeds aimed at increasing agricultural productivity. The company is on track with several seed traits in different stages of the approval process, including its GMO Phytase Corn, which is awaiting variety approval. Chairman Dr. Gengchen Han highlights the potential for a lucrative market opportunity amid this transformation.
Origin Agritech Ltd. (NASDAQ: SEED) has received a RMB6.5 million grant from China's Ministry of Agriculture for its GMO corn traits, GH5112E-117C and G1105E-823. This funding aims to enhance agricultural technology innovation and supports the final steps towards obtaining bio-safety certificates for these traits. The successful evaluation marks a significant progress in Origin's research and reflects strong governmental support for GMO initiatives in China. CEO Dr. Gengchen Han expressed optimism about the contributions of this technology to Chinese agriculture.